COPD and Response to Traffic Related Particles

慢性阻塞性肺病和对交通相关颗粒的反应

基本信息

  • 批准号:
    8265466
  • 负责人:
  • 金额:
    $ 64.96万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-06-05 至 2017-02-28
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Chronic obstructive pulmonary disease (COPD) is a common disease that results in considerable morbidity and mortality. Epidemiological studies indicate that persons with COPD are particularly susceptible to the effects of traffic related particles. To date, our knowledge regarding these effects is mostly derived from community-based epidemiologic studies using administrative databases and population exposures. Epidemiological observations indicating effects in large population samples have not yet been demonstrated in patients with COPD and the mechanisms of disease remain uncertain. Previous efforts to study the health effects of air pollution in patients with COPD have been limited by inadequate sample size, an inadequate assessment of personal exposure, and lack of a suitable cohort. We have addressed these limitations and will study the effects of traffic-related pollution in 300 persons with moderate to severe COPD recruited from patients receiving clinical care at VA Boston. We hypothesize that when assessed over one year, exposure to traffic-related particles as measured by black carbon will result in exacerbations of COPD, a reduction in pulmonary function, an increase in measures of systemic inflammation, and an increase in systemic oxidative stress in a dose-related manner. Exposure will be assessed by a Boston-area black carbon spatio-temporal land use regression model with model validation by in-home monitoring The information obtained from this research project will define the exposure response relationships between traffic-related particles and the clinical, pulmonary, and systemic responses to air pollution in patients with COPD. PUBLIC HEALTH RELEVANCE: COPD is a common disease that results in considerable morbidity and mortality. Epidemiologic studies have identified these patients as a group susceptible to the adverse effects of traffic related air pollution. We will examine the dose response relationship between traffic related air pollution exposures with exacerbations, change in pulmonary function, and systemic response in patients with COPD.
描述(由申请人提供):慢性阻塞性肺疾病(COPD)是一种常见疾病,导致相当高的发病率和死亡率。流行病学研究表明,慢性阻塞性肺病患者特别容易受到与交通有关的颗粒物的影响。迄今为止,我们关于这些影响的知识主要来自基于社区的流行病学研究,使用行政数据库和人口暴露。流行病学观察表明,在COPD患者中尚未证实在大人群样本中有效果,疾病机制仍不确定。以往研究空气污染对慢性阻塞性肺病患者健康影响的努力受到样本量不足、个人暴露评估不足以及缺乏合适队列的限制。我们已经解决了这些局限性,并将研究交通相关污染对300名中重度COPD患者的影响,这些患者从VA Boston接受临床治疗的患者中招募。我们假设,在一年多的评估中,暴露于交通相关的黑碳颗粒会导致COPD加重,肺功能下降,全身性炎症增加,并以剂量相关的方式增加全身性氧化应激。通过波士顿地区黑碳时空土地利用回归模型评估暴露,并通过家庭监测验证模型。本研究项目获得的信息将定义交通相关颗粒与慢性阻塞性肺病患者对空气污染的临床、肺部和全身反应之间的暴露反应关系。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ERIC GARSHICK其他文献

ERIC GARSHICK的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ERIC GARSHICK', 18)}}的其他基金

CMA: Pulmonary and Systemic Effects of Deployment Related Particulate Matter Exposures
CMA:与部署相关的颗粒物暴露对肺部和全身的影响
  • 批准号:
    10436775
  • 财政年份:
    2020
  • 资助金额:
    $ 64.96万
  • 项目类别:
CMA: Pulmonary and Systemic Effects of Deployment Related Particulate Matter Exposures
CMA:与部署相关的颗粒物暴露对肺部和全身的影响
  • 批准号:
    10553622
  • 财政年份:
    2020
  • 资助金额:
    $ 64.96万
  • 项目类别:
Retrospective assessment of radon progeny and pollution effects in COPD
氡子体和 COPD 污染影响的回顾性评估
  • 批准号:
    9980902
  • 财政年份:
    2019
  • 资助金额:
    $ 64.96万
  • 项目类别:
Vitamin D, Respiratory Function, and Illness in Chronic SCI
维生素 D、呼吸功能和慢性 SCI 中的疾病
  • 批准号:
    8593481
  • 财政年份:
    2013
  • 资助金额:
    $ 64.96万
  • 项目类别:
Vitamin D, Respiratory Function, and Illness in Chronic SCI
维生素 D、呼吸功能和慢性 SCI 中的疾病
  • 批准号:
    9173417
  • 财政年份:
    2013
  • 资助金额:
    $ 64.96万
  • 项目类别:
COPD and Response to Traffic Related Particles
慢性阻塞性肺病和对交通相关颗粒的反应
  • 批准号:
    8481548
  • 财政年份:
    2012
  • 资助金额:
    $ 64.96万
  • 项目类别:
Determinants of Telomere Length in Chronic SCI: A Pilot Study
慢性 SCI 端粒长度的决定因素:一项初步研究
  • 批准号:
    8274496
  • 财政年份:
    2012
  • 资助金额:
    $ 64.96万
  • 项目类别:
Determinants of Telomere Length in Chronic SCI: A Pilot Study
慢性 SCI 端粒长度的决定因素:一项初步研究
  • 批准号:
    8495804
  • 财政年份:
    2012
  • 资助金额:
    $ 64.96万
  • 项目类别:
COPD and Response to Traffic Related Particles
慢性阻塞性肺病和对交通相关颗粒的反应
  • 批准号:
    8619624
  • 财政年份:
    2012
  • 资助金额:
    $ 64.96万
  • 项目类别:
Blood Markers of Mobile Source Particle Exposure
移动源粒子暴露的血液标记
  • 批准号:
    7146757
  • 财政年份:
    2006
  • 资助金额:
    $ 64.96万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 64.96万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 64.96万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 64.96万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 64.96万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 64.96万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 64.96万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 64.96万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 64.96万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 64.96万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 64.96万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了